Regulatory & Legal

Founder Chuck Cohn pours millions more into his ed-tech firm, a bold move that signals deep confidence despite a slumping stock and cautious analysts.

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

A new partnership aims to accelerate driver safety tech in next-gen vehicles, merging AI monitoring with a fortress-like operating system.

With blockbuster sales from VYJUVEK, Krystal Biotech heads to J.P. Morgan with investors eager for news on its global growth and ambitious pipeline.

A new integration brings Ceres AI's insights directly into the John Deere Operations Center, tackling data fragmentation for growers and insurers alike.

China's ETF market had a record 2025, fueled by AI breakthroughs and state support. A look at the boom, the leaders, and the risks ahead.

The new over-the-counter molecular test could deliver results in 30 minutes, aiming to revolutionize STI diagnostics and tap into a $1.5B market.

Tango Therapeutics adds seasoned CFO Sung Lee to its board, a strategic move to guide its lead cancer drug, vopimetostat, through late-stage trials.

In a major win, Rockwell Medical extends its DaVita supply deal through 2026 with a price hike, underscoring the value of its reliable supply chain.

Kodiak AI partners with automotive giant Bosch to scale autonomous truck hardware, a landmark deal set to accelerate the driverless freight revolution.

A new collaboration brings a sci-fi concept to life, promising to transform car interiors and safety for the coming age of personal autonomous vehicles.

Solmate Infrastructure appoints financial heavyweight Erez Simha to its board, bolstering its ambitious plan to build a Solana hub in Abu Dhabi.

Northann Corp. stock soars on a major retail partnership, but can its innovative 3D printing tech overcome deep financial woes and a delisting threat?

All eyes are on GH Research ahead of a crucial Jan. 5 announcement on the FDA status of its fast-acting drug for treatment-resistant depression.

Sony Honda Mobility's high-tech AFEELA 1 EV has started trial runs in Ohio, introducing a unique 'Quality Gate' to ensure its advanced tech is flawless.

A new study finds traditional banks reject 93% of emergency loan seekers, pushing millions toward predatory lenders with 400%+ APR. Is fintech the answer?

Quectel's new AR588MA is the first automotive module with 3GPP R18 5G-Advanced, promising a leap in autonomous driving and connected car reliability.

Entertainment giant Banijay divests its majority stake in bet-at-home to fund a landmark merger with Tipico, reshaping its gaming strategy and the market.

Occidental nets $9.7B from its OxyChem sale to Berkshire Hathaway, pivoting to oil and carbon capture while retaining significant environmental liabilities.

Tesla's Q4 report shows a complex picture. Vehicle deliveries fell short, but record-breaking growth in the energy division hints at a major strategic shift.